WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Tuesday, November 24, 2015

Parkinson Disease-Spotlight on Treatment Advances Webinar/Teleconference, January 26, 2016 launched by the American Parkinson Disease Association

November 30, 2015 (PRWEB) November 24, 2015 -- 

Understanding treatment options to provide the best quality of life for those living with Parkinson’s  New York, NY –
The American Parkinson Disease Association (APDA) is pleased to announce a new Webinar/Teleconference program, “Parkinson Disease-Spotlight on Treatment Advances” on Tuesday, January 26, 2016 (12:00PM–1:00PM ET; 11:00AM–12:00PM CT; 10:00AM–11:00AM MT; 9:00AM–10:00AM PT). This program, funded by AbbVie, will provide an expert perspective on the latest treatment advances for Parkinson’s disease. 
“The importance of timely information cannot be overvalued when you are living day to day with a chronic disease”, said Leslie A. Chambers, President & CEO of APDA. “Many Parkinson’s patients do not see their clinicians on a regular basis, and frequently only when they have symptom management problems. This teleconference will provide a scan of the current treatment options for Parkinson’s disease patients, newly released products and a brief review of potential promising therapies in the pipeline.”
David G. Standaert, MD, PhD, Chairman of APDA’s Scientific Advisory Board and John N. Whitaker Professor and Chair of Neurology at The University of Alabama Birmingham School of Medicine will present this program designed to provide people with Parkinson’s, care partners, family members, and healthcare providers an important overview of the options available today. 
Click here to register online. To register by phone, please call toll-free (800) 223-2732.
A confirmation including program details will be sent upon registering for the program.
American Parkinson Disease Association 

The American Parkinson Disease Association (APDA) was founded in 1961 with the dual purpose to Ease the Burden - Find the Cure for Parkinson's disease. In that time, APDA has raised and invested more than $87 million to fund research, patient services and education, and elevate public awareness. As the country's largest Parkinson's grassroots organization, APDA aims to Ease the Burden for the more than one million Americans with Parkinson's disease and their families through a nationwide network of Chapters, Information and Referral (I&R) Centers, and support groups. APDA pursues its efforts to Find the Cure by funding Centers for Advanced Research and awarding grants to fund the most promising research toward discovering the cause(s) and finding the cure for Parkinson's disease.

AbbVie 

AbbVie, is a global, researched-based biopharmaceutical company, is committed to ongoing Parkinson's education to raise awareness about the condition, and research to improve the lives of those living with and impacted by this disease. 
CONTACT: 
Stephanie Paul | APDA Vice President Marketing & Development | 718-981-8062 | spaul(at)apdaparkinson(dot)org

For the original version on PRWeb visit: http://www.prweb.com/releases/2015/11/prweb13096081.htm

No comments:

Post a Comment